NCT04232371

Brief Summary

Compare the effectiveness and safety of two techniques for modification of slow AV nodal pathway conduction underlying AVNRT: 1) New Ablation Technique, low voltage and wave front collision mapping vs. 2) the Standard Ablation Technique, an anatomical/electrogram approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

July 15, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

2.5 years

First QC Date

January 6, 2020

Last Update Submit

July 26, 2022

Conditions

Keywords

New Ablation TechniqueStandard Ablation Technique

Outcome Measures

Primary Outcomes (1)

  • Primary end point - Number of lesions needed to achieve modification of slow AV nodal pathway

    Number of ablation lesion needed to achieve modification of slow AV nodal pathway conduction underlying AVNRT as defined by one of the following: 1. Absent SVT induction 2. Loss of slow pathway function as defined by no jumps (discontinuity in AV conduction curve) or unable to sustain PR \> RR during rapid atrial pacing 3. Persistence of dual pathway physiology with no echo beat 4. Persistence of dual pathway physiology with single echo beat

    During procedure- start to finish

Secondary Outcomes (1)

  • Secondary End points - Time from start to end of ablation lesion application(s), and total length of procedure.

    During procedure- start to finish

Study Arms (2)

New Ablation Technique

ACTIVE COMPARATOR

Will undergo ablation using voltage mapping and triangle of Koch propagation wave collision mapping. Ablation will be performed at or slightly above the site of wave front collision.

Procedure: New Ablation Technique

Standard Ablation Technique

ACTIVE COMPARATOR

Ablation performed using the traditional anatomical / electrogram guided ablation approach.

Procedure: Standard Ablation Technique

Interventions

Patient will undergo ablation using voltage mapping and triangle of Koch propagation wave collision mapping. Ablation will be performed at or slightly above the site of wave front collision.

New Ablation Technique

Ablation performed using the traditional anatomical / electrogram guided ablation approach.

Standard Ablation Technique

Eligibility Criteria

AgeUp to 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Weight \>15 kg
  • Age \< 21 years old
  • Simple CHD acceptable to enroll (Table 1):
  • Table 1. Diagnoses in Adult Patients with Simple Congenital Heart Disease
  • Isolated congenital aortic valve disease
  • Isolated congenital mitral valve disease (eg, except parachute valve, cleft leaflet)
  • Small atrial septal defect
  • Isolated small ventricular septal defect (no associated lesions)
  • Mild pulmonary stenosis
  • Small patent ductus arteriosus
  • Repaired conditions
  • Previously ligated or occluded ductus arteriosus
  • Repaired secundum or sinus venosus atrial septal defect without residua
  • Repaired ventricular septal defect without residua

You may not qualify if:

  • Additional mechanism(s) for SVT in addition to AV nodal reentry tachycardia.
  • Moderate or Complex Congenital Heart Disease, see tables 2 and 3.
  • Table 2. Diagnoses in Adult Patients with Congenital Heart Disease of Moderate Complexity
  • Aorto-left ventricular fistulas
  • Anomalous pulmonary venous drainage, partial or total
  • Atrioventricular septal defects (partial or complete)
  • Coarctation of the aorta
  • Ebstein's anomaly
  • Infundibular right ventricular outflow obstruction of significance
  • Ostium primum atrial septal defect
  • Patent ductus arteriosus (not closed)
  • Pulmonary valve regurgitation (moderate to severe)
  • Pulmonary valve stenosis (moderate to severe)
  • Sinus of Valsalva fistula/aneurysm
  • Sinus venosus atrial septal defect
  • +24 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Children's National Hospital

Washington D.C., District of Columbia, 20010, United States

RECRUITING

Memorial Health System

Hollywood, Florida, 33021, United States

RECRUITING

Univeristy of Iowa

Iowa City, Iowa, 52242, United States

RECRUITING

University of Louisville

Louisville, Kentucky, 40202, United States

RECRUITING

University of Wisconsin

Madison, Wisconsin, 53792, United States

RECRUITING

Related Publications (14)

  • Philip Saul J, Kanter RJ; WRITING COMMITTEE; Abrams D, Asirvatham S, Bar-Cohen Y, Blaufox AD, Cannon B, Clark J, Dick M, Freter A, Kertesz NJ, Kirsh JA, Kugler J, LaPage M, McGowan FX, Miyake CY, Nathan A, Papagiannis J, Paul T, Pflaumer A, Skanes AC, Stevenson WG, Von Bergen N, Zimmerman F. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm. 2016 Jun;13(6):e251-89. doi: 10.1016/j.hrthm.2016.02.009. Epub 2016 Feb 17. No abstract available.

    PMID: 26899545BACKGROUND
  • Papagiannis J, Beissel DJ, Krause U, Cabrera M, Telishevska M, Seslar S, Johnsrude C, Anderson C, Tisma-Dupanovic S, Connelly D, Avramidis D, Carter C, Kornyei L, Law I, Von Bergen N, Janusek J, Silva J, Rosenthal E, Willcox M, Kubus P, Hessling G, Paul T; Pediatric and Congenital Electrophysiology Society. Atrioventricular Nodal Reentrant Tachycardia in Patients With Congenital Heart Disease: Outcome After Catheter Ablation. Circ Arrhythm Electrophysiol. 2017 Jul;10(7):e004869. doi: 10.1161/CIRCEP.116.004869. Epub 2017 Jul 7.

    PMID: 28687669BACKGROUND
  • Markowitz SM, Lerman BB. A contemporary view of atrioventricular nodal physiology. J Interv Card Electrophysiol. 2018 Aug;52(3):271-279. doi: 10.1007/s10840-018-0392-5. Epub 2018 Jun 16.

    PMID: 29909540BACKGROUND
  • Lee PC, Chen SA, Hwang B. Atrioventricular node anatomy and physiology: implications for ablation of atrioventricular nodal reentrant tachycardia. Curr Opin Cardiol. 2009 Mar;24(2):105-12. doi: 10.1097/HCO.0b013e328323d83f.

    PMID: 19225293BACKGROUND
  • Malloy L, Law IH, Von Bergen NH. Voltage mapping for slow-pathway visualization and ablation of atrioventricular nodal reentry tachycardia in pediatric and young adult patients. Pediatr Cardiol. 2014 Jan;35(1):103-7. doi: 10.1007/s00246-013-0748-7. Epub 2013 Jul 20.

    PMID: 23872907BACKGROUND
  • Van Aartsen A, Law IH, Maldonado JR, Von Bergen NH. Propagation Mapping Wave Collision Correlates to the Site of Successful Ablation During Voltage Mapping in Atrioventricular Nodal Reentry Tachycardia. J Innov Card Rhythm Manag. 2017 Sep 15;8(9):2836-2842. doi: 10.19102/icrm.2017.080905. eCollection 2017 Sep.

    PMID: 32494469BACKGROUND
  • Collins KK, Dubin AM, Chiesa NA, Avasarala K, Van Hare GF. Cryoablation versus radiofrequency ablation for treatment of pediatric atrioventricular nodal reentrant tachycardia: initial experience with 4-mm cryocatheter. Heart Rhythm. 2006 May;3(5):564-70. doi: 10.1016/j.hrthm.2006.01.026. Epub 2006 Feb 28.

    PMID: 16648062BACKGROUND
  • Kammeraad J, Udink ten Cate F, Simmers T, Emmel M, Wittkampf FH, Sreeram N. Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in children aided by the LocaLisa mapping system. Europace. 2004 May;6(3):209-14. doi: 10.1016/j.eupc.2004.02.004.

    PMID: 15121072BACKGROUND
  • Kriebel T, Bertram H, Windhagen-Mahnert B, Bokenkamp R, Kaulitz R, Rohloff A, Peuster M, Hausdorf G, Paul T. [Atrioventricular nodal reentry tachycardia in children: curative treatment by high frequency catheter ablation]. Z Kardiol. 2000 Jun;89(6):538-45. doi: 10.1007/s003920070226. German.

    PMID: 10929439BACKGROUND
  • Rhodes LA, Wieand TS, Vetter VL. Low temperature and low energy radiofrequency modification of atrioventricular nodal slow pathways in pediatric patients. Pacing Clin Electrophysiol. 1999 Jul;22(7):1071-8. doi: 10.1111/j.1540-8159.1999.tb00572.x.

    PMID: 10456636BACKGROUND
  • Teixeira OH, Balaji S, Case CL, Gillette PC. Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in children. Pacing Clin Electrophysiol. 1994 Oct;17(10):1621-6. doi: 10.1111/j.1540-8159.1994.tb02355.x.

    PMID: 7800563BACKGROUND
  • Papagiannis J, Papadopoulou K, Rammos S, Katritsis D. Cryoablation versus radiofrequency ablation for atrioventricular nodal reentrant tachycardia in children: long-term results. Hellenic J Cardiol. 2010 Mar-Apr;51(2):122-6.

    PMID: 20378513BACKGROUND
  • PASS 15 Power Analysis and Sample Size Software (2017). NCSS, LLC. Kaysville, Utah, USA, ncss.com/software/pass.

    BACKGROUND
  • Chow, S.C.; Shao, J.; Wang, H. 2003. Sample Size Calculations in Clinical Research. Marcel Dekker. New York.

    BACKGROUND

MeSH Terms

Conditions

Tachycardia, Supraventricular

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jeffrey Moak

    Children's National Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized within each participating center, not by center, into study groups: 1. New Ablation Technique - will undergo ablation using voltage mapping and triangle of Koch propagation wave collision mapping. Ablation will be performed at or slightly above the site of wave front collision. 2. Standard Ablation Technique - ablation performed using the traditional anatomical / electrogram guided ablation approach. Randomization will occur through a module in Redcap.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director, Electrophysiology and Pacing, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

January 6, 2020

First Posted

January 18, 2020

Study Start

July 15, 2020

Primary Completion

January 1, 2023

Study Completion

March 1, 2023

Last Updated

July 28, 2022

Record last verified: 2022-07

Locations